Development and experimental validation of an M2 macrophage and platelet‐associated gene signature to predict prognosis and immunotherapy sensitivity in bladder cancer
Cancer Science · 2024-05 · 115 (5) · 1417-1432
DOI: 10.1111/cas.16113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 29.02.2024. Verfasst von Bahaerguli Muhuitijiang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Blood Platelets, Immunotherapy, Macrophages, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Guangzhou Municipal Science and Technology Project.
Abstract (Originalsprache)
Platelets and M2 macrophages both play crucial roles in tumorigenesis, but their relationship and the prognosis value of the relative genes in bladder cancer (BLCA) remain obscure. In the present study, we found that platelets stimulated by BLCA cell lines could promote M2 macrophage polarization, and platelets were significantly associated with the infiltration of M2 macrophages in BLCA samples. Through the bioinformatic analyses, A2M , TGFB3 , and MYLK , which were associated with platelets and M2 macrophages, were identified and verified in vitro and then included in the predictive model. A platelet and M2 macrophage‐related gene signature was constructed to evaluate the prognosis and immunotherapeutic sensitivity, helping to guide personalized treatment and to disclose the underlying mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- The First Clinical Medical College of Southern Medical University, Guangzhou, Guangdong, China.
ORCID-Profile: Zhiyong Zhang, Wanlong Tan
Förderung
- National Natural Science Foundation of China
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Muhuitijiang, B., Zhou, J., Zhou, R., Zhang, Z., Yan, G., Zheng, Z., Zeng, X., Zhu, Y., Wu, H., Gao, R., Zhu, T., Shi, X., & Tan, W. (2024). Development and experimental validation of an M2 macrophage and platelet‐associated gene signature to predict prognosis and immunotherapy sensitivity in bladder cancer. Cancer Science, 115(5), 1417-1432. https://doi.org/10.1111/cas.16113
Vancouver
Muhuitijiang B, Zhou J, Zhou R, Zhang Z, Yan G, Zheng Z, et al. Development and experimental validation of an M2 macrophage and platelet‐associated gene signature to predict prognosis and immunotherapy sensitivity in bladder cancer. Cancer Science. 2024;115(5):1417-1432. doi:10.1111/cas.16113
BibTeX
@article{Muhuitijiang2024,
author = {Muhuitijiang, Bahaerguli and Zhou, Jiawei and Zhou, Ranran and Zhang, Zhiyong and Yan, Guang and Zheng, Zaosong and Zeng, Xiangbo and Zhu, Yuanchao and Wu, Haowei and Gao, Ruxi and Zhu, Tianhang and Shi, Xiaojun and Tan, Wanlong},
title = {Development and experimental validation of an M2 macrophage and platelet‐associated gene signature to predict prognosis and immunotherapy sensitivity in bladder cancer},
journal = {Cancer Science},
year = {2024},
volume = {115},
number = {5},
pages = {1417--1432},
doi = {10.1111/cas.16113}
}
EUVIMED